Feasibility and efficacy of helical intensity-modulated radiotherapy for stage III non-small cell lung cancer in comparison with conventionally fractionated 3D-CRT

BACKGROUND: The standard treatment for stage III non-small-cell lung cancer (NSCLC) is still 60 Gy in conventional fractions combined with concurrent chemotherapy; however, the resulting local controls are disappointing. The aim of this study was to compare and assess the feasibility and efficacy of...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:J Thorac Dis
Główni autorzy: He, Jian, Huang, Yan, Chen, Yixing, Shi, Shiming, Ye, Luxi, Hu, Yong, Zhang, Jianying, Zeng, Zhaochong
Format: Artigo
Język:Inglês
Wydane: AME Publishing Company 2016
Hasła przedmiotowe:
Original Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4842790/
https://ncbi.nlm.nih.gov/pubmed/27162660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2016.03.46
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy